Optimization system of mesenchymal stem cells for tissue engineering chondrogenic differentiation

Q4 Medicine
Pan Wu, Zhuo Pei, W. Zeng
{"title":"Optimization system of mesenchymal stem cells for tissue engineering chondrogenic differentiation","authors":"Pan Wu, Zhuo Pei, W. Zeng","doi":"10.3760/CMA.J.ISSN.0253-2352.2020.04.007","DOIUrl":null,"url":null,"abstract":"Articular cartilage defect is a common joint damage, however, due to the particularity of cartilage tissue, its repair ability is limited. Thus, articular cartilage damage often changes to more severe osteoarthritis which brings huge pain and economic burden to patients. The development of cartilage tissue engineering brings good news to these patients, but also faces great challenges. Because of the characteristics of mesenchymal stem cells(MSCs) including autologous source, amplification and cartilage differentiation potential, MSCs are often used as the seed cells of cartilage tissue engineering and got widely attention. In the commonly used treatment strategy of articular cartilage differentiated from mesenchymal cells, in vitro pre culture and differentiation showed good therapeutic effects.The mesenchymal stem cells collected from the patient were concentrated, cultured and induced differentiation in vitro, a certain number of differentiated chondrocytes were obtained, and then the cells and culture matrix were transplanted to the patient together. However, the tissue engineering cartilage obtained from mesenchymal stem cells cannot fully meet the requirements of clinical treatment. Moreover, due to the differences of disease type, degree and individuality, there are various optimized factors for the treatment of MSCs derived tissue-engineered cartilage transplantation. For the same type of disease treatment, the optimization system still has no unified recognized standard. In order to obtain better adapt to the human body and meet the clinical requirements of articular cartilage, this review focus onoptimized factors of MSCs in the treatment of orthopedic diseases, summarize and analysis the research status, and discuss the induced factorsfrom three aspects: environmental factors, scaffold selection and seed cells.It provides an idea for using mesenchymal stem cells to obtain better tissue-engineered cartilage and to establish a better optimization system.","PeriodicalId":36405,"journal":{"name":"中华骨科杂志","volume":"40 1","pages":"244-256"},"PeriodicalIF":0.0000,"publicationDate":"2020-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华骨科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.0253-2352.2020.04.007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Articular cartilage defect is a common joint damage, however, due to the particularity of cartilage tissue, its repair ability is limited. Thus, articular cartilage damage often changes to more severe osteoarthritis which brings huge pain and economic burden to patients. The development of cartilage tissue engineering brings good news to these patients, but also faces great challenges. Because of the characteristics of mesenchymal stem cells(MSCs) including autologous source, amplification and cartilage differentiation potential, MSCs are often used as the seed cells of cartilage tissue engineering and got widely attention. In the commonly used treatment strategy of articular cartilage differentiated from mesenchymal cells, in vitro pre culture and differentiation showed good therapeutic effects.The mesenchymal stem cells collected from the patient were concentrated, cultured and induced differentiation in vitro, a certain number of differentiated chondrocytes were obtained, and then the cells and culture matrix were transplanted to the patient together. However, the tissue engineering cartilage obtained from mesenchymal stem cells cannot fully meet the requirements of clinical treatment. Moreover, due to the differences of disease type, degree and individuality, there are various optimized factors for the treatment of MSCs derived tissue-engineered cartilage transplantation. For the same type of disease treatment, the optimization system still has no unified recognized standard. In order to obtain better adapt to the human body and meet the clinical requirements of articular cartilage, this review focus onoptimized factors of MSCs in the treatment of orthopedic diseases, summarize and analysis the research status, and discuss the induced factorsfrom three aspects: environmental factors, scaffold selection and seed cells.It provides an idea for using mesenchymal stem cells to obtain better tissue-engineered cartilage and to establish a better optimization system.
间充质干细胞向组织工程软骨分化的优化体系
关节软骨缺损是一种常见的关节损伤,但由于软骨组织的特殊性,其修复能力有限。因此,关节软骨损伤往往演变为更严重的骨关节炎,给患者带来巨大的疼痛和经济负担。软骨组织工程的发展给这些患者带来了好消息,但也面临着巨大的挑战。由于间充质干细胞(MSCs)具有自体来源、扩增和软骨分化潜能等特点,常被用作软骨组织工程的种子细胞而受到广泛关注。在关节软骨间充质细胞分化的常用治疗策略中,体外预培养和分化均表现出良好的治疗效果。收集患者的间充质干细胞,在体外浓缩培养诱导分化,获得一定数量的分化软骨细胞,然后将细胞与培养基质一起移植到患者体内。然而,间充质干细胞获得的组织工程软骨还不能完全满足临床治疗的需要。此外,由于疾病类型、程度和个性的差异,MSCs来源的组织工程软骨移植治疗存在多种优化因素。对于同类型疾病的治疗,优化系统仍没有统一的公认标准。为了获得更好地适应人体和满足临床要求的关节软骨,本文重点对MSCs在骨科疾病治疗中的优化因素进行综述和分析,并从环境因素、支架选择和种子细胞三个方面对诱导因素进行探讨。这为利用间充质干细胞获得更好的组织工程软骨和建立更好的优化体系提供了思路。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
中华骨科杂志
中华骨科杂志 Medicine-Surgery
CiteScore
0.80
自引率
0.00%
发文量
8153
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信